XOMA Revenue and Competitors
Estimated Revenue & Valuation
- XOMA's estimated annual revenue is currently $75M per year.
- XOMA's estimated revenue per employee is $630,252
- XOMA's total funding is $155.8M.
Employee Data
- XOMA has 119 Employees.
- XOMA grew their employee count by 2% last year.
XOMA's People
Name | Title | Email/Phone |
---|---|---|
1 | VP, Corporate Controller | Reveal Email/Phone |
2 | Chief Investment Officer | Reveal Email/Phone |
3 | Director Corporate Development | Reveal Email/Phone |
4 | Senior Accounting Manager | Reveal Email/Phone |
5 | Senior Accountant | Reveal Email/Phone |
XOMA Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is XOMA?
XOMA develops biopharmaceuticals that target cancer, immunological disorders and infectious diseases while leveraging its development and manufacturing infrastructure through partnerships with other pharmaceutical companies.
keywords:N/A$155.8M
Total Funding
119
Number of Employees
$75M
Revenue (est)
2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
XOMA News
Several other research analysts also recently commented on XOMA. TheStreet raised shares of XOMA from a c- rating to a b- rating in a report...
Get XOMA alerts: Institutional investors and hedge funds have recently bought and sold shares of the stock. Geneos Wealth Management Inc.
XOMA's milestone and royalty aggregator business model began to demonstrate its potential in 2021 and the first few months of 2022. There are...
EMERYVILLE, Calif., April 06, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced the pricing of its underwritten registered public offering of 1,400,000 depositary shares at an initial public offering price of $25.00 per depositary share, raising g ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $17.9M | 119 | 6% | N/A |
#2 | $35M | 119 | 4% | N/A |
#3 | $25M | 119 | -4% | N/A |
#4 | $34.5M | 119 | 3% | N/A |
#5 | $25.2M | 120 | 12% | N/A |